ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease

被引：48

作者：

Reiter-Brennan, Cara ^{[1
,2
]}

Osei, Albert D. ^{[1
,2
]}

Uddin, S. M. Iftekhar ^{[1
,2
]}

Orimoloye, Olusola A. ^{[1
,2
,3
]}

Obisesan, Olufunmilayo H. ^{[1
,2
]}

Mirbolouk, Mohammadhassan ^{[1
,2
,4
]}

Blaha, Michael J. ^{[1
,2
]}

Dzaye, Omar ^{[1
,2
,5
]}

机构：

[1] Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD USA

[2] Charite, Dept Radiol & Neuroradiol, Berlin, Germany

[3] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN USA

[4] Yale Sch Med, Dept Med, New Haven, CT USA

[5] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2020年 / 87卷 / 04期

关键词：

CORONARY-ARTERY CALCIUM; WHITE SUBJECTS; STATIN USE; RISK; MANAGEMENT; EZETIMIBE; EFFICACY; SAFETY;

D O I：

10.3949/ccjm.87a.19078

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The 2018 and 2019 guidelines from the American College of Cardiology and American Heart Association reflect the complexity of individualized cholesterol management. The documents address more detailed risk assessment, newer nonstatin cholesterol-lowering drugs, special attention to patient subgroups, and consideration of the value of therapy, all with the aim of creating personalized treatment plans for each patient. Overall, the guidelines recommend shared decision-making to meet the individual needs of each patient.

引用

页码：231 / 239

页数：9

共 50 条

[31] Highlights from the 2020 ACC/AHA guidelines on valvular heart disease
Barbanti, Marco
Costa, Giuliano
EUROINTERVENTION, 2021, 16 (16) : 1303 - 1305
[32] ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
Warnes, Carole A.
Williams, Roberta G.
Bashore, Thomas M.
Child, John S.
Connolly, Heidi M.
Dearani, Joseph A.
del Nido, Pedro
Fasules, James W.
Graham, Thomas P., Jr.
Hijazi, Ziyad M.
Hunt, Sharon A.
King, Mary Etta
Landzberg, Michael J.
Miner, Pamela D.
Radford, Martha J.
Walsh, Edward P.
Webb, Gary D.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (23) : E1 - E121
[33] What is new in the 2006 ACC/AHA guidelines on valvular heart disease?
Carabello B.A.
Current Cardiology Reports, 2008, 10 (2) : 85 - 90
[34] STATE-OF-THE-ART CVD PREVENTION: LOOKING BEYOND AND INTERPRETING THE ACC/AHA PREVENTION OF CARDIOVASCULAR DISEASE GUIDELINES
Wong, N. D.
CARDIOLOGY, 2015, 131 : 330 - 330
[35] AHA Updates Guidelines for CPR and Emergency Cardiovascular Care
Hauk, Lisa
AMERICAN FAMILY PHYSICIAN, 2016, 93 (09) : 791 - 797
[36] AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions
Arnett, Donna K.
Goodman, Richard A.
Halperin, Jonathan L.
Anderson, Jeffrey L.
Parekh, Anand K.
Zoghbi, William A.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (17) : 1851 - 1856
[37] Comparison of Transatlantic Approaches to Lipid Management: The AHA/ACC/Multisociety Guidelines vs the ESC/EAS Guidelines
Singh, Maninder
McEvoy, John W.
Khan, Safi U.
Wood, David A.
Graham, Ian M.
Blumenthal, Roger S.
Mishra, Abhishek K.
Michos, Erin D.
MAYO CLINIC PROCEEDINGS, 2020, 95 (05) : 998 - 1014
[38] Comment on the 2013 ACC/AHA Guidelines on Lifestyle Management to Reduce Cardiovascular Risk by the JAS Guidelines Committee
Koba, Shinji
Maruyama, Chizuko
Sasaki, Jun
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 (05) : 375 - 377
[39] Impact of ACC/AHA guidelines for coronary artery disease in asymptomatic type 2 diabetic patients at low risk of cardiovascular disease
Moriconi, D.
Nesti, L.
Mengozzi, A.
Trico, D.
Natali, A.
Taddei, S.
Nannipieri, M.
DIABETOLOGIA, 2019, 62 : S571 - S571
[40] EVALUATING THE 2018 AHA/ACC LIPID GUIDELINE PERFORMANCE TO IDENTIFY PATIENTS AT HIGH RISK FOR PREMATURE CARDIOVASCULAR DISEASE
Zeitouni, Michel
Nanna, Michael G.
Sun, Jie-Lena
Chiswell, Karen
Peterson, Eric D.
Navar, Ann Marie
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1981 - 1981

← 1 2 3 4 5 →